MedPath

Efficacy of the additional effect of LTRA to the asthmatics who has taken both ICS and LABA.

Not Applicable
Conditions
bronchial asthma
Registration Number
JPRN-UMIN000002367
Lead Sponsor
Kansai Asthma Research Network:KAR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patient who has previous history of side effect or hypersensitivity serious compared with element of research medicine 2)Patient judged to be improper according to doctor when targeting it

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Amount of change of ACT number (for four weeks)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath